Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8945 |
High Similarity |
NPD7470 |
Discontinued |
0.8756 |
High Similarity |
NPD7944 |
Discontinued |
0.8744 |
High Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.8663 |
High Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.8579 |
High Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.8502 |
High Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.8454 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7951 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7790 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7952 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7950 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7953 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7789 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7791 |
Approved |
0.8325 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.8325 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.8318 |
Intermediate Similarity |
NPD7781 |
Approved |
0.8318 |
Intermediate Similarity |
NPD7780 |
Approved |
0.8261 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.8238 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.8238 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.8238 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.8238 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.8211 |
Intermediate Similarity |
NPD482 |
Approved |
0.8196 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.8196 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.8186 |
Intermediate Similarity |
NPD7730 |
Approved |
0.8186 |
Intermediate Similarity |
NPD7731 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7970 |
Approved |
0.8182 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.8168 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8111 |
Intermediate Similarity |
NPD7824 |
Approved |
0.81 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.81 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.8098 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.8093 |
Intermediate Similarity |
NPD7271 |
Approved |
0.8086 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.8058 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.8041 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8019 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.8019 |
Intermediate Similarity |
NPD8322 |
Phase 2 |
0.801 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.799 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD7711 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7934 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7913 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7889 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7879 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7846 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7816 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7793 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7751 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD7688 |
Phase 1 |
0.7725 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7725 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7714 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD8289 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD484 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7642 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7621 |
Intermediate Similarity |
NPD6449 |
Clinical (unspecified phase) |
0.7621 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7604 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7596 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD8356 |
Approved |
0.7583 |
Intermediate Similarity |
NPD8114 |
Approved |
0.7583 |
Intermediate Similarity |
NPD8115 |
Approved |
0.7576 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7561 |
Intermediate Similarity |
NPD6665 |
Discontinued |
0.7555 |
Intermediate Similarity |
NPD7576 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD8430 |
Approved |
0.7524 |
Intermediate Similarity |
NPD7727 |
Phase 2 |
0.7523 |
Intermediate Similarity |
NPD8271 |
Discontinued |
0.7511 |
Intermediate Similarity |
NPD8372 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7477 |
Intermediate Similarity |
NPD7716 |
Approved |
0.7477 |
Intermediate Similarity |
NPD7717 |
Approved |
0.7476 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7465 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD7777 |
Approved |
0.7464 |
Intermediate Similarity |
NPD7778 |
Approved |
0.7464 |
Intermediate Similarity |
NPD53 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7451 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.7441 |
Intermediate Similarity |
NPD7817 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7409 |
Intermediate Similarity |
NPD6578 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD8119 |
Discontinued |
0.7398 |
Intermediate Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7387 |
Intermediate Similarity |
NPD6615 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.7366 |
Intermediate Similarity |
NPD8103 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7363 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7354 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.7336 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7878 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD4602 |
Approved |
0.7313 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7313 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7311 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7311 |
Intermediate Similarity |
NPD4500 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.73 |
Intermediate Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.7295 |
Intermediate Similarity |
NPD2564 |
Approved |
0.7295 |
Intermediate Similarity |
NPD2565 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7269 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7264 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7249 |
Intermediate Similarity |
NPD6263 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6965 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6452 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.722 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7217 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.721 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD5487 |
Phase 1 |
0.7207 |
Intermediate Similarity |
NPD8256 |
Approved |
0.7207 |
Intermediate Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD8257 |
Approved |
0.7206 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD6249 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD6248 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD8169 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD6173 |
Approved |
0.7163 |
Intermediate Similarity |
NPD4334 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD8374 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD7921 |
Approved |
0.7157 |
Intermediate Similarity |
NPD5897 |
Approved |
0.7157 |
Intermediate Similarity |
NPD5899 |
Approved |
0.7157 |
Intermediate Similarity |
NPD5898 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8122 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7865 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7137 |
Intermediate Similarity |
NPD8247 |
Approved |
0.7137 |
Intermediate Similarity |
NPD8246 |
Approved |
0.7136 |
Intermediate Similarity |
NPD7946 |
Pre-registration |
0.7136 |
Intermediate Similarity |
NPD4397 |
Phase 1 |
0.7136 |
Intermediate Similarity |
NPD5475 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD8063 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD8329 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7689 |
Approved |
0.71 |
Intermediate Similarity |
NPD4885 |
Approved |
0.7097 |
Intermediate Similarity |
NPD8098 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4900 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7085 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD6977 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD6978 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD3794 |
Approved |
0.7072 |
Intermediate Similarity |
NPD3795 |
Approved |
0.7069
|
Intermediate Similarity |
NPD8047 |
Clinical (unspecified phase) |